Asker Healthcare Group AB (SE:ASKER)
:ASKER
Want to see SE:ASKER full AI Analyst Report?
ASKER Stock Chart & Stats
kr82.25
--
Market closed
kr82.25
--
Day’s Range― - ―
52-Week Rangekr58.64 - kr111.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.96M
Market Cap
kr28.99B
Enterprise Valuekr33.87B
Total Cash (Recent Filing)kr884.00M
Total Debt (Recent Filing)kr5.81B
Price to Earnings (P/E)63.2
Beta0.65
Next Earnings
May 19, 2026EPS Estimate
0.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.67
Shares Outstanding383,706,480
10 Day Avg. Volume378,678
30 Day Avg. Volume1,960,693
Financial Highlights & Ratios
PEG Ratio1.92
Price to Book (P/B)4.74
Price to Sales (P/S)1.85
P/FCF Ratio42.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr100.00Price Target Upside21.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.77
Revenue Forecast (FY)kr18.92B
Bulls Say, Bears Say
Bulls Say
Revenue Growth AccelerationA sustained revenue acceleration to ~38.6% in 2025 signals durable demand expansion and successful commercial execution. Persistent top-line growth supports scale economies, funds reinvestment and reduces reliance on one-time gains, strengthening medium-term cash generation and strategic optionality.
Improving Gross And Operating MarginsMaterial improvement in gross margin and rising operating margins point to sustainable operational gains—better pricing, mix, or cost control. Higher structural margins increase resilience to cost shocks, improve free cash flow potential and provide room to invest in growth without eroding core profitability.
Consistent Positive And Rising Free Cash FlowStrong, rising operating cash flow and consistent positive free cash flow underpin financial flexibility. Durable cash generation supports debt reduction, capital expenditure, and strategic investments while lowering refinancing dependence and enabling sustained execution of the business model over the medium term.
Bears Say
Thin And Volatile Net MarginsNet margins near 3% with historical volatility mean limited earnings buffer. For a business with capital intensity or leverage, small cost or revenue swings can erase profitability, constraining retained earnings and limiting the company’s ability to consistently fund growth or absorb adverse industry shocks.
Remaining Leverage / Capital Structure RiskAlthough leverage has improved, a debt-to-equity around 1.0 remains material for a low-net-margin healthcare operator. Ongoing interest and principal obligations limit financial flexibility, raise refinancing risk, and magnify downside in slower revenue or margin compression scenarios over the medium term.
Weaker Cash Conversion Versus Net IncomeDeclining FCF-to-net-income ratio signals weaker conversion of accounting profits into spendable cash, possibly from working capital or non-cash items. Lower conversion reduces capacity to deleverage, invest, or return cash to stakeholders, making the business more reliant on external funding during stress.
Asker Healthcare Group AB News
ASKER FAQ
What was Asker Healthcare Group AB’s price range in the past 12 months?
Asker Healthcare Group AB lowest stock price was kr58.64 and its highest was kr111.88 in the past 12 months.
What is Asker Healthcare Group AB’s market cap?
Asker Healthcare Group AB’s market cap is kr28.99B.
When is Asker Healthcare Group AB’s upcoming earnings report date?
Asker Healthcare Group AB’s upcoming earnings report date is May 19, 2026 which is in 15 days.
How were Asker Healthcare Group AB’s earnings last quarter?
Asker Healthcare Group AB released its earnings results on Feb 10, 2026. The company reported kr0.67 earnings per share for the quarter, beating the consensus estimate of kr0.657 by kr0.013.
Is Asker Healthcare Group AB overvalued?
According to Wall Street analysts Asker Healthcare Group AB’s price is currently Undervalued.
Does Asker Healthcare Group AB pay dividends?
Asker Healthcare Group AB does not currently pay dividends.
What is Asker Healthcare Group AB’s EPS estimate?
Asker Healthcare Group AB’s EPS estimate is 0.56.
How many shares outstanding does Asker Healthcare Group AB have?
Asker Healthcare Group AB has 383,706,480 shares outstanding.
What happened to Asker Healthcare Group AB’s price movement after its last earnings report?
Asker Healthcare Group AB reported an EPS of kr0.67 in its last earnings report, beating expectations of kr0.657. Following the earnings report the stock price went down -11.687%.
Which hedge fund is a major shareholder of Asker Healthcare Group AB?
Currently, no hedge funds are holding shares in SE:ASKER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asker Healthcare Group AB
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products; and health-related protection and trauma products for emergency care, police service, and military. In addition, it offers develops and sells disposable medical supplies under the Evercare, Selefa, and Embra brands; distributes eye surgery products; and develops and sells products for time-management, communication, and cognition for schools, assistive technology centres, and other public services. Further, the company provides support and assistance to people needing wound, diabetes, and urological care; ostomy, urology, and rehab services; ambulance services; products for physiotherapy practices; supplies exercise and treatment equipment and measurement; and sells and rents out various mobility aids and rehab products, such as pressure-relieving mattresses and cushions, as well as manufactures and distributes pressure care products. The company operates in Sweden, Norway, Finland, Estonia, Latvia, Lithuania, Netherlands, Belgium, Luxembourg, Denmark, the United Kingdom, Ireland, Germany, Austria, Switzerland, Czech Republic, and Poland. Asker Healthcare Group AB was founded in 2018 and is based in Danderyd, Sweden.
ASKER Stock 12 Month Forecast
Average Price Target
kr100.00
▲(21.58% Upside)
Technical Analysis
Options Prices
Currently, No data available
---